WORCESTER, MA – Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC) announced today that human embryonic stem cell (hESC) line MA135 was unanimously approved for federal funding at the 100th Meeting of the Advisory Committee to the Director (ACD) National Institutes of Health (NIH). In addition to MA135, seven additional stem cell lines derived at ACT are currently under review by...
The National Institutes of Health is proposing to expand its definition of human embryonic stem cells, enabling the university researchers it finances to work with cells derived from a very early human egg. The proposal will benefit several academic researchers and a company, Advanced Cell Technology, that has filed a request with the Food and Drug Administration to test a treatment for macular...
The National Institutes of Health is proposing a small change to the definition of “human embryonic stem cell” that could have a big effect on their long-term ability to lead to cures for a variety of diseases. President Obama asked the NIH to come up with new guidelines for funding human embryonic stem cell (hESC) research, and those guidelines define the cells as ones that...